Article: Ceradyne, Inc. Reports Third Quarter, Nine-Month 2009 Financial Results.(Financial report)

Ceradyne, Inc. (Nasdaq:CRDN) reported financial results for the third quarter and nine months ended September 30, 2009.

Sales for the third quarter 2009 were $108.0 million, compared with $167.7 million in third quarter 2008. Net income for the three months ended September 30, 2009 was $4.9 million, or $0.19 per fully diluted share. The net income for the third quarter 2009 included a pre-tax charge for losses on auction rate securities of $1.8 million that reduced earnings per share by approximately $0.07.

The Company is adjusting its guidance for the full fiscal year 2009 from $.70 per fully diluted share to approximately $.60 per fully diluted share ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!